2008
DOI: 10.1002/dvg.20367
|View full text |Cite
|
Sign up to set email alerts
|

Efficient, inducible Cre‐recombinase activation in vascular endothelium

Abstract: In recent years, gene-targeting studies in mice have elucidated many molecular mechanisms in vascular biology. However, it has been difficult to apply this approach to the study of postnatal animals because mutations affecting the vasculature are often embryonically lethal. We have therefore generated transgenic mice that express a tamoxifen-inducible form of Cre recombinase (iCreER(T2)) in vascular endothelial cells using a phage artificial chromosome (PAC) containing the Pdgfb gene (Pdgfb-iCreER mice). This … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

10
293
0

Year Published

2010
2010
2018
2018

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 264 publications
(303 citation statements)
references
References 21 publications
(24 reference statements)
10
293
0
Order By: Relevance
“…To generate inducible, endothelialspecific mouse mutants for VEGFR2 and VEGFR3, we crossbred PdgfbiCreER T2 (21) and Cdh5-PAC-CreER T2 (22) mice with mice homozygous for the conditional Vegfr2 (23) (Vegfr2 flox/flox ) Significance VEGF/VEGFR and Notch signaling pathways are major molecular regulators of sprouting angiogenesis. Here we investigated the cross-talk between VEGFR and Notch signaling by using state-of-the-art inducible genetic mouse models.…”
Section: Resultsmentioning
confidence: 99%
“…To generate inducible, endothelialspecific mouse mutants for VEGFR2 and VEGFR3, we crossbred PdgfbiCreER T2 (21) and Cdh5-PAC-CreER T2 (22) mice with mice homozygous for the conditional Vegfr2 (23) (Vegfr2 flox/flox ) Significance VEGF/VEGFR and Notch signaling pathways are major molecular regulators of sprouting angiogenesis. Here we investigated the cross-talk between VEGFR and Notch signaling by using state-of-the-art inducible genetic mouse models.…”
Section: Resultsmentioning
confidence: 99%
“…Since our study, Dr. Nusse's group identified ECs lining the central vein as the source of Wnt2 and Wnt9b in regulating β‐catenin activation and target gene expression in pericentral hepatocytes 8. We also employed platelet‐derived growth factor i‐Cre‐ERT2 to generate EC‐Wls‐KO; this led to a mosaic recombination insufficient to draw concrete conclusions, likely due to a different transgenic line 26. Eventually, we employed transgenic mice expressing Cre recombinase under Lyve1 promoter to delete Wls from ECs in the liver.…”
Section: Discussionmentioning
confidence: 99%
“…More than 60% of these mice developed spontaneous (mostly multicentric) hemangiosarcoma by the average age of 25 wk. To further restrict p53 loss to the vascular endothelial lineages, other endothelialspecific Cre lines that have temporal control of Cre activity, such as VE-cadherin-CreER(T2) 30 or PDGFB-iCreER(T2), 31 could be used to avoid Cre activity in the hemogenic endothelium during development: this would thereby restrict p53 loss to the neonatal or adult endothelium and avoid p53 loss in the hematopoietic system. 32 We expect that such mice will only develop hemangiosarcomas.…”
Section: Discussionmentioning
confidence: 99%